1. Liu, Xujin, Zhang, Fan, Fan, Yuchen, Qiu, Cheng, Wang, Kai. 2024. MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway. In International immunopharmacology, 142, 113107. doi:10.1016/j.intimp.2024.113107. https://pubmed.ncbi.nlm.nih.gov/39276458/
2. Zhou, Huandi, Jiang, Le, Wang, Guohui, Hou, Liubing, Xue, Xiaoying. 2021. Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma. In BioMed research international, 2021, 7479326. doi:10.1155/2021/7479326. https://pubmed.ncbi.nlm.nih.gov/34961841/
3. Sheng, Yue, Wei, Jiangbo, Yu, Fang, He, Chuan, Qian, Zhijian. . A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. In Blood, 138, 2838-2852. doi:10.1182/blood.2021011707. https://pubmed.ncbi.nlm.nih.gov/34255814/
4. Wu, Xianxian, Sui, Zhilin, Zhang, Hongdian, Wang, Ying, Yu, Zhentao. 2020. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. In Frontiers in oncology, 10, 554759. doi:10.3389/fonc.2020.554759. https://pubmed.ncbi.nlm.nih.gov/33042838/
5. Zheng, Ruinian, Lai, Guowei, Li, Rongfa, Cai, Limin, Jia, Jun. . Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma. In Journal of gastrointestinal oncology, 12, 153-173. doi:10.21037/jgo-20-574. https://pubmed.ncbi.nlm.nih.gov/33708433/
6. Xu, Yan, Yang, Xueling, Si, Tongguo, Xing, Wenge, Guo, Zhi. 2021. MCM4 in human hepatocellular carcinoma: a potent prognostic factor associated with cell proliferation. In Bioscience trends, 15, 100-106. doi:10.5582/bst.2021.01016. https://pubmed.ncbi.nlm.nih.gov/33716256/
智鼠故事 
